Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L18 pseudogene 2 (RPL18P2) is a processed pseudogene in the human genome related to the ribosomal protein L18 gene. It is located on chromosome 1 (chr1:182,328,497-182,329,007, hg38). While the parent gene RPL18 codes for a structural protein of the 60S ribosomal subunit involved in translation, RPL18P2 does not encode any functional protein due to its pseudogene status. Processed pseudogenes are typically DNA segments derived from reverse transcription events of mature mRNA, resulting in sequences that lack introns and functional regulatory elements. They are generally not transcribed or translated but may sometimes have regulatory effects at the RNA level in rare cases. RPL18P2 has no documented biological function or involvement in disease. In summary: RPL18P2 is a noncoding pseudogene, not a therapeutic target, not associated with disease or drug interactions, and its only notable features are its genomic location and origin as a processed ribosomal protein L18 pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L18 pseudogene 2 (RPL18P2).